Detalhe da pesquisa
1.
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
Cell
; 183(4): 1058-1069.e19, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33058755
2.
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly.
J Immunol
; 208(5): 1001-1005, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121642
3.
Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination.
J Clin Immunol
; 43(5): 869-881, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932291
4.
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations.
Mult Scler
; 29(7): 884-888, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974938
5.
Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
J Immunol
; 206(11): 2614-2622, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980583
6.
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
Ann Rheum Dis
; 81(6): 881-888, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288376
7.
Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis.
Mult Scler
; 28(7): 1041-1050, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575234
8.
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.
J Infect Dis
; 223(5): 796-801, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064789
9.
Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021.
Emerg Infect Dis
; 27(8): 2169-2173, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102098
10.
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany.
Emerg Infect Dis
; 27(8): 2174-2178, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102097
11.
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
Transfus Med Hemother
; 48(3): 137-147, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34177417
12.
Clinical Outcome and Viral Genome Variability of Hepatitis B Virus-Induced Acute Liver Failure.
Hepatology
; 69(3): 993-1003, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30229977
13.
Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.
Gut
; 68(5): 893-904, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580250
14.
NK cells improve control of friend virus infection in mice persistently infected with murine cytomegalovirus.
Retrovirology
; 10: 58, 2013 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23738889
15.
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron.
iScience
; 26(4): 106323, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36925720
16.
A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity.
Sci Rep
; 13(1): 21846, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071261
17.
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
RMD Open
; 8(2)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597977
18.
SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.
Front Immunol
; 13: 840126, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35359967
19.
Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles.
Front Immunol
; 13: 1045498, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36439181
20.
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies.
Science
; 375(6582): 782-787, 2022 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076281